1. Epigenetic polypharmacology: A new frontier for epi‐drug discovery
   Daniela Tomaselli et al, 2020, Medicinal Research Reviews CrossRef
2. Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
   Johanna S. Ungerstedt, 2018, International Journal of Molecular Sciences CrossRef
3. Epigenetic treatment‑mediated modulation of PD‑L1 predicts potential therapy resistance over response markers in myeloid malignancies: A molecular mechanism involving effectors of PD‑L1 reverse signaling
   Hongbin Liu et al, 2018, Oncology Letters CrossRef
4. Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab
   Estefanía García-Guerrero et al, 2017, Blood CrossRef